Cancer

Akari Therapeutics Joins Webull Corporate Connect Service Platform

Innovative targeted oncology company built on next-generation ADCs and a novel discovery engine Connect with the Company on Webull here…

11 months ago

Akari Therapeutics Joins Webull Corporate Connect Service Platform

Innovative targeted oncology company built on next-generation ADCs and a novel discovery engine Connect with the Company on Webull here…

11 months ago

Salarius Pharmaceuticals Announces Patient Enrollment to Resume in Investigator-initiated Phase 1/2 Clinical Trial Using Seclidemstat with Azacitidine to Treat Hematologic Cancers

HOUSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) announces that patient enrollment will resume in the…

11 months ago

Salarius Pharmaceuticals Announces Patient Enrollment to Resume in Investigator-initiated Phase 1/2 Clinical Trial Using Seclidemstat with Azacitidine to Treat Hematologic Cancers

HOUSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) announces that patient enrollment will resume in the…

11 months ago

Vor Bio to Participate in the Oppenheimer’s 35th Annual Healthcare Life Sciences Conference

CAMBRIDGE, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today…

11 months ago

Vor Bio to Participate in the Oppenheimer’s 35th Annual Healthcare Life Sciences Conference

CAMBRIDGE, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today…

11 months ago

BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS™ monotherapyNo toxicity…

11 months ago

BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS™ monotherapyNo toxicity…

11 months ago

Izotropic to Present at Investor Conference February 6th

- CEO to present overview of Company value proposition, unique catalysts, and near-term objectives -- Event includes live Q and…

11 months ago

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series

Registration Link for Presentation and live Q&A to take place, Tuesday February 4, 2025 at 2:00 pm ESTMarlborough, Massachusetts--(Newsfile Corp.…

11 months ago